Synopsys, Inc. $SNPS Shares Acquired by Bath Savings Trust Co

Bath Savings Trust Co increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,221 shares of the semiconductor company’s stock after acquiring an additional 1,365 shares during the period. Bath Savings Trust Co’s holdings in Synopsys were worth $5,315,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SNPS. BlackRock Inc. purchased a new stake in Synopsys during the second quarter worth about $7,228,099,000. State Street Corp lifted its position in shares of Synopsys by 0.3% during the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock worth $4,128,317,000 after purchasing an additional 28,532 shares in the last quarter. Van ECK Associates Corp boosted its stake in shares of Synopsys by 19.7% in the second quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after purchasing an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after purchasing an additional 892,736 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Synopsys by 39.5% in the second quarter. Assenagon Asset Management S.A. now owns 2,455,402 shares of the semiconductor company’s stock valued at $1,095,281,000 after purchasing an additional 695,146 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: New AI chip-design alliances with OpenAI and Amazon reinforce Synopsys’ position as a key supplier of software used to design advanced AI semiconductors. The expanded Amazon relationship has been described as a potential $1 billion opportunity. Synopsys Is Up 17.7% After New AI Chip-Design Alliances With OpenAI And Amazon
  • Positive Sentiment: Synopsys’ board authorized a $1 billion share-repurchase program, potentially covering about 1.1% of outstanding shares. Buybacks can support earnings per share and signal management believes the stock has long-term value. Stock Repurchase Program Declared by Synopsys
  • Positive Sentiment: Recent commentary argues SNPS remains strategically important because AI chips generally require Synopsys software before reaching fabrication. Analysts and investors have also lifted fair-value estimates following the AI partnerships and Investor Day, suggesting the long-term growth outlook may offset concerns about acquisition debt and slower overall EDA growth. Synopsys Stock Fair Value Edges Higher After AI Deals And Investor Day
  • Neutral Sentiment: Synopsys trades at a demanding valuation, with a price-to-earnings ratio near 89 and a PEG ratio near 2.0. A comparison with Progress Software highlights the debate over whether SNPS’ AI exposure justifies its premium relative to other software stocks. PRGS vs. SNPS: Which Stock Should Value Investors Buy Now?
  • Negative Sentiment: CFO Sudhindra Kankanwadi sold a combined 12,170 shares for roughly $6.0 million across October 5 and 6, reducing his direct holdings by about 40%. Although insider sales do not necessarily indicate deteriorating fundamentals, the transactions may weigh on sentiment after the recent rally. Synopsys Insider Selling
  • Negative Sentiment: One market analysis notes that SNPS shares have declined after several recent earnings beats, suggesting investor expectations are unusually high and that strong results may already be priced in. Synopsys Is Hot Again But a Pattern Has Emerged

Analyst Ratings Changes

A number of equities research analysts have issued reports on SNPS shares. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. Benchmark restated a “buy” rating and issued a $570.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $640.00 price objective on shares of Synopsys in a research report on Thursday, October 1st. Piper Sandler upgraded Synopsys from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Finally, Mizuho decreased their target price on Synopsys from $600.00 to $550.00 and set an “outperform” rating for the company in a report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $584.11.

Read Our Latest Stock Report on Synopsys

Insider Activity at Synopsys

In other Synopsys news, insider Janet Lee sold 1,144 shares of the stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider directly owned 16,534 shares in the company, valued at $8,308,665.68. This represents a 6.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Aart de Geus sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the sale, the insider directly owned 120,421 shares in the company, valued at approximately $53,197,180.96. The trade was a 17.19% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 102,559 shares of company stock valued at $44,607,141. Company insiders own 0.56% of the company’s stock.

Synopsys Stock Down 0.5%

NASDAQ SNPS traded down $2.50 during trading on Wednesday, reaching $502.67. 1,631,983 shares of the company’s stock were exchanged, compared to its average volume of 2,036,859. The stock has a market cap of $96.33 billion, a P/E ratio of 88.81, a price-to-earnings-growth ratio of 1.99 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The company has a 50 day moving average price of $412.43 and a two-hundred day moving average price of $437.43. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The business had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the business posted $3.39 EPS. The business’s revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.

Synopsys declared that its Board of Directors has initiated a stock repurchase program on Monday, October 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Synopsys Profile

(Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.